Revere Asset Management Inc Invests $317,000 in Liquidia Corporation $LQDA

Revere Asset Management Inc purchased a new position in shares of Liquidia Corporation (NASDAQ:LQDA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 9,201 shares of the company’s stock, valued at approximately $317,000. Liquidia comprises about 0.1% of Revere Asset Management Inc’s portfolio, making the stock its 24th largest position.

A number of other large investors have also modified their holdings of LQDA. NewEdge Advisors LLC purchased a new stake in shares of Liquidia during the second quarter worth about $25,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in Liquidia in the third quarter valued at approximately $30,000. FNY Investment Advisers LLC purchased a new stake in Liquidia in the third quarter valued at approximately $34,000. Covestor Ltd boosted its position in Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after buying an additional 359 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Liquidia by 281.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after buying an additional 4,927 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Insider Buying and Selling at Liquidia

In other Liquidia news, CEO Roger Jeffs sold 32,744 shares of the business’s stock in a transaction that occurred on Monday, April 13th. The stock was sold at an average price of $38.37, for a total value of $1,256,387.28. Following the completion of the transaction, the chief executive officer directly owned 1,137,599 shares of the company’s stock, valued at approximately $43,649,673.63. The trade was a 2.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stephen M. Bloch sold 318,893 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $50.23, for a total value of $16,017,995.39. Following the completion of the transaction, the director directly owned 1,870,042 shares of the company’s stock, valued at $93,932,209.66. The trade was a 14.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 1,047,713 shares of company stock valued at $46,156,003. 25.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on LQDA shares. Needham & Company LLC upped their target price on Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, May 11th. BTIG Research upped their target price on Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Wells Fargo & Company upped their target price on Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a research report on Tuesday, May 12th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Finally, HC Wainwright upped their target price on Liquidia from $55.00 to $67.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Liquidia currently has a consensus rating of “Moderate Buy” and an average target price of $49.33.

Liquidia Stock Performance

Shares of NASDAQ:LQDA opened at $60.98 on Tuesday. Liquidia Corporation has a 12-month low of $11.85 and a 12-month high of $62.30. The company has a market capitalization of $5.42 billion, a PE ratio of 435.60 and a beta of 0.41. The business has a 50 day moving average of $42.53 and a two-hundred day moving average of $37.56. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. The firm’s revenue was up 4187.1% compared to the same quarter last year. As a group, analysts forecast that Liquidia Corporation will post 2.97 EPS for the current year.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).